Clinical Trials Logo

Filter by:
NCT ID: NCT05939388 Completed - Pain Clinical Trials

Battlefield Auricular Acupressure (BAApress) Feasibility Study

Start date: November 14, 2023
Phase: N/A
Study type: Interventional

The purpose of this research study is to find out what effects (good and bad) acupressure applied to the outside of the ear (Auricular Acupressure), in addition to the standard of care medication regimen, will have on pain. This study is being done to assess whether acupressure in addition to prescribed pain medication may be of benefit in decreasing pain levels and improving overall wellbeing. This study will also evaluate the feasibility of routinely offering acupressure to patients having pain issues in addition to a psychiatric diagnosis.

NCT ID: NCT05939011 Completed - Ketosis Clinical Trials

Ketogenic Diet Health and Longevity

KDHL
Start date: April 8, 2022
Phase: N/A
Study type: Interventional

The goal of this pilot intervention is to learn about how a well-formulated ketogenic diet (WFKD) impacts various health factors in generally healthy adults. The main questions it aims to answer are: - Establish whether an 8-week isocaloric, WFKD improves body composition and metabolic biomarkers in adults without chronic disease. - Examine changes in transcriptomic sequencing pathways pre- and post-WFKD intervention. - Explore gut microbial changes in adults without chronic disease that consume a WFKD. Participants will follow a well-formulated ketogenic diet for 8-weeks. Study procedures include: - Weekly body weight tracking - Daily urinary ketone assessment - Pre/post stool samples for gut microbiota analyses - Pre/post DXA scans - Diet quality tracking through 3-day food records

NCT ID: NCT05938933 Completed - Obesity Clinical Trials

Personalized Health Planning--Shared Medical Appointments for Obesity

Start date: February 19, 2020
Phase: N/A
Study type: Interventional

Obesity affects a large portion of our population and accounts for a significant individual health burden for both individual patients and society. Though as little as 3 to 5% weight loss is associated with significant clinical benefits,1,2 current approaches to treat patients with obesity are not providing patients with the interventions needed to routinely see this change. One potential solution to this problem is utilizing personalized health planning (PHP) shared medical appointments (SMAs) to address the treatment of obesity. As PHP SMA has shown to improve clinical outcomes and patient satisfaction when compared to traditional care in other chronic illnesses,3,4 it could also be useful as a strategy to improve the efficiency and effectiveness of treating patients with obesity.

NCT ID: NCT05938452 Completed - Clinical trials for Neurological Disorder

Safety and Tolerability of Glyceryl Tribenzoate (GTB) Capsules in Healthy Subjects

Start date: December 12, 2022
Phase: Phase 1
Study type: Interventional

This study is designed to assess the safety and PK/PD of GTB and Benzoic Acid (Benzoate) using a single ascending dose (SAD) study (under fasting conditions).

NCT ID: NCT05938413 Completed - HIV/AIDS Clinical Trials

Community Health Worker And MHealth to ImProve Viral Suppression (CHAMPS Pilot)

CHAMPS Pilot
Start date: July 20, 2023
Phase: N/A
Study type: Interventional

The overall goal of this study is to evaluate the feasibility of a remotely delivered CHAMPS intervention for people living with HIV (PLWH) in a randomized controlled trial. The proposed trial is scientifically significant in representing a principled and systematic effort to test the efficacy of a combined community health worker (CHW) and smartphone intervention linked to a smart pill box for antiretroviral (ART) adherence in PLWH in the United States (US). Guided by a rigorous theoretical model of supportive accountability and building on preliminary work, this intervention has the potential to enable PLWH to self-manage their ART regimens while CHW monitor their ART adherence in real-time ultimately leading to viral suppression and ART adherence.

NCT ID: NCT05938010 Completed - Astigmatism Clinical Trials

Subjective Wearing Experience of the Total30 for Astigmatism Lens Among Satisfied Biofinity Toric Lens Wearers

Start date: July 25, 2023
Phase:
Study type: Observational

To subjectively evaluate wearing experience in the T30fA lens among subjects who were already satisfied with their Biofinity Toric lenses.

NCT ID: NCT05937126 Completed - Clinical trials for Lower Respiratory Tract Infections

Rapid Diagnostic Supporting Antimicrobial Stewardship in Patients With Pneumonia

Start date: September 15, 2020
Phase:
Study type: Observational

The purpose of this study is to determine whether or not the FilmArray Penumonia Panel adds value to patient care.

NCT ID: NCT05937087 Completed - Clinical trials for Mental Health Wellness 1

Developing Community Partnerships Through Research to Define Community Well-Being With Three (Diné) Navajo Communities

Start date: March 17, 2018
Phase:
Study type: Observational

This community engaged research pilot project begins a process of engaging Navajo community members from the communities of Counselor, Ojo Encino, and Torreon chapters in northwest New Mexico in critical dialogue and praxis to address longstanding health disparities. The research design is based on a Tribal Crit theoretical framework that aims to explore the perspectives of community members' understandings of wellbeing from a Diné centered paradigm using a community based participatory research approach integrated with a Diné-centered scientific research methodology. The proposed aims include using the Diné conceptualization of K'é (kinship) to define community wellbeing with future plans to build upon this knowledge by developing a community profile survey for obtaining baseline community health information that can be used to inform future research studies. A long-term goal of this mixed-method, community-based participatory research (CBPR) study is to create a community-university research partnership in an Indigenous context by establishing a multi-dimensional, Diné-centered research infrastructure with the capacity to improve mental/behavioral health outcomes and reduce health disparities. The creation of this infrastructure is a critical first step that will make it possible to use health research to positively transform the health landscape in Indigenous communities

NCT ID: NCT05936502 Completed - Clinical trials for Head and Neck Squamous Cell Carcinoma

Ascertaining the Radiologic Prognostic Importance of Extranodal Extension on Imaging (iENE) in Head and Neck Cancer

EPIC-iENE DATA
Start date: July 11, 2022
Phase:
Study type: Observational

Extranodal extension (ENE) refers to the spread of head and neck squamous cell carcinoma (HNSCC) outside the lymph nodes. It is a well-known factor that indicates a poorer prognosis and outcome for patients who have undergone surgical removal of the cancer. In such cases, it is recommended to combine chemotherapy with radiation therapy after surgery. As the number of cases of HNSCC related to the human papillomavirus (HPV) is increasing, treatment approaches have shifted towards using radiation therapy as the primary treatment method instead of surgery. This raises an important question about the significance of ENE observed through imaging tests (referred to as iENE) and its impact on the prognosis. Unfortunately, this question remains unanswered. The objective of this project is to conduct a comprehensive study across multiple medical institutions. The investigators will gather data including scan results, histopathology reports, and data from patient charts from individuals who have been treated for head and neck cancer. The aim is to analyze and correlate the findings between the pathological evidence of ENE and the imaging results, while also assessing the prognostic value of iENE. Additionally, the investigators will explore the influence of HPV status on these factors. By collecting and analyzing this data, the investigators hope to establish standardized criteria that can assist radiologists in accurately identifying ENE through imaging tests. This research is essential for enhancing our understanding of HNSCC and improving the effectiveness of diagnostic procedures and treatment planning.

NCT ID: NCT05936489 Completed - Presbyopia Clinical Trials

Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Start date: July 6, 2023
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, randomized study to assess the plasma pharmacokinetic profile of LNZ101 and LNZ100.